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Abstract 
 
Background Pain is a frequently reported symptom of inflammatory bowel disease (IBD) 
experienced by patients in active disease and remission. Psychological factors play a significant role 
in pain, but have not been systematically reviewed in IBD.  
Aim To review psychosocial factors associated with pain in adults diagnosed with IBD. 
Methods Electronic (PsycInfo, MEDLINE, EMBASE, Cochrane Library, CINAHL, Web of Science) 
and hand-searching were conducted February-May 2017. Two authors carried out screening and data 
extraction. 
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Results Fifteen studies including 5539 IBD patients were identified. Emotional, cognitive-
behavioural and personality factors were associated with IBD-pain. Depression and anxiety were the 
most commonly explored constructs, followed by perceived stress and pain catastrophising, all of 
which were positively associated with greater pain. Greater abdominal pain was associated with a 
concurrent mood disorder over fivefold (OR 5.76, 95% CI 1.39, 23.89). Coping strategies and pain 
fear avoidance correlated with pain levels. Perceived social support (r = .26) and internal locus of 
control (r= .33) correlated with less pain. Patients reporting pain in IBD remission more frequently 
had an existing diagnosis of a mood disorder, a chronic pain disorder and irritable bowel syndrome. 
Six studies controlled for disease activity, of which 4 found that psychosocial factors significantly 
predicted pain. The majority of studies (n=10) were of high quality. 
Conclusion Psychosocial factors appear to play a significant role in IBD-pain. Further research is 
required to explore psychosocial constructs in relation to IBD-pain, with use of validated pain 
measures, large sample sizes and clearer characterisation of disease activity. 
Key words: inflammatory bowel disease, Crohn’s disease, ulcerative colitis, pain, psychosocial, 
psychological factors, systematic review 
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Short title: Psychosocial factors and pain in IBD 
 
Introduction  
 
Abdominal pain is a commonly experienced and debilitating symptom of IBD, with up to 70% of 
patients experiencing pain when the disease is active1-3. Common causes of IBD-related abdominal 
pain include acute inflammation, strictures, adhesions, small-bowel obstruction and bowel 
dysmotility4. Reducing abdominal pain is a key therapeutic target for IBD therapy, however pain 
severity does not always correlate with endoscopic and clinical biomarkers, and a significant 
proportion of patients (20-50%) report ongoing pain during periods of remission3, 5-7. Bodily pain, 
cramps and extra intestinal manifestations of IBD such as arthralgia are also reported by patients3, 8. In 
an IBD population-based cohort, peripheral arthritis and non-inflammatory joint pain were reported 
by 0.4% and 16% of patients, respectively9. The prevalence of chronic widespread pain or 
fibromyalgia has ranged between 3.5-30% in adults with IBD10, 11. Suggested causes of extra intestinal 
manifestations of pain in IBD include genetic predisposition, such as polymorphisms of the NOD2 
gene involved in the transcription of proinflammatory cytokines and chemokines, or the migration of 
gut lymphocytes9, 12. Research has shown the capacity of activated intestinal lymphocytes to enter the 
joints and adhere to inflamed synovial vessels13. Such processes within the ‘joint-gut axis’ are 
suggested to explain the high co-occurrence of IBD and arthropathies, however research into this area 
of IBD-pain has received much less attention.  
 
Chronic pain in IBD is a complex phenomenon driven by a range of peripheral and central nervous 
system (CNS) processes. In the case of acute pain, noxious signalling is processed by sensory afferent 
nerves that innervate the gut wall and send signals from the lower gastrointestinal tract to the CNS via 
the dorsal spinal horn14. However, recurrent inflammation and release of mucosal signalling 
molecules (e.g. nerve growth factor, glial cell-lined derived neurotrophic factor and ion channel 
expression TRPV1/TRPA1) in the context of chronic IBD can result in visceral hypersensitivity1, 14. In 
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CNS processing, recurrent visceral stimulation can lead to the activation of the N-methyl-D-aspartate 
receptor and influx of calcium in higher/second-order sensory neurons, resulting in long-lasting 
neuronal excitability in the absence of inflammation15. Central processing within the brain such as 
stress and arousal may also have a role in pain perception and aetiology of chronic IBD-pain, such as 
via mechanisms along the ‘brain-gut’ axis. Stress can exacerbate IBD symptoms by the production of 
cortisol and catecholamines from the hypothalamic-pituitary-adrenal and sympathetic-adrenal-
medullary axis and thereby the release of circulating inflammatory cytokines (e.g IL-6)16, 17. 
Emotional and cognitive processes can also amplify perception of incoming visceral signals by 
modulating descending inhibitory processes18. Similar mechanisms have been recognised in irritable 
bowel syndrome (IBS), and functional symptoms in quiescent IBD are frequently entangled with a 
diagnosis of IBS19, 20. However, there is mixed support as to whether conceptualising symptoms in 
quiescent IBD as IBS is useful.  
 
Current treatments for pain management in IBD carry a number of risks and limitations. Escalating 
pharmacotherapy or exploratory surgery for pain in the absence of inflammation can have iatrogenic 
side effects, potentially exacerbating disease activity, psychological distress and worsening quality of 
life for patients. Alternative options such as antispasmodics, anticonvulsants, tricyclic antidepressants 
and cyclooxygenase-2 (COX-2) inhibitors may provide pain relief, yet their long-term use can 
exacerbate gut symptoms and bowel dysmotility17. A significant number of patients use opioids or 
marijuana for pain control despite psychological and disease-related risks21-24. In a European IBD 
cohort (n = 2831), 21.5% and 14.7% of patients were reported to take antidepressant or opioid 
medication, respectively25. Norton et al.26 recently reviewed abdominal pain management 
interventions in IBD and found promising evidence for psychological approaches for IBD pain. For 
example, self-directed and therapist-led stress management27, coping skills28 and disease anxiety-
related cognitive behavioural therapy (CBT)29, all appear to attenuate abdominal pain symptoms, 
albeit in predominantly small samples. Adjuvant psychological therapy may be particularly effective 
for individuals with IBD in pain, at risk of psychological distress and who are experiencing ongoing 
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symptoms in the absence of active disease30. Yet the review highlighted the need for evidence-based 
theory to aid the development of effective psychosocial interventions for IBD-pain. 
 
Bielefeldt et al have proposed a biopsychosocial model of IBD-pain1. This identifies two key 
processes of hypersensitivity and hypervigilance in the aetiology of chronic pain, summarising the 
role of inflammation and visceral hypersensitivity in increasing central processing of pain, and the 
influence of emotional responses and mood disorders that can act to amplify the pain experience by 
disinhibition of descending signals1 (Figure 1). The model has provided a useful insight into the 
possible mechanisms of chronic IBD-pain, however it is yet to be thoroughly investigated. 
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Figure 1. Bielefeld et al.’s (2009, p. 20) conceptual model of pain in IBD. Two distinct processes of 
hypervigilance and hypersensitivity are suggested to underlie greater pain. Recurrent inflammatory 
activity can lead to hypersensitivity of visceral neurons, resulting in increased central input of pain 
signals. Emotional reactivity to the affective dimension of pain (valence) can cause an individual to 
become hypervigilant, leading to disinhibition of descending pathways and further increase of sensory 
input. 
 
 
Despite pain being rated as one of patients’ most bothersome symptoms in IBD31,32, this remains an 
area of limited research. In addition to the disease, the symptom of pain specifically has a profound 
impact on the quality of life and functioning of IBD patients3. To date, systematic reviews in IBD 
have explored the role of psychosocial factors on the course of IBD and associated psychotherapeutic 
approaches33, psychosocial correlates of adjustment in IBD34 and pain management interventions in 
IBD26. However, a systematic review of psychosocial factors in IBD-pain specifically is lacking. A 
comprehensive profile of psychological and social factors associated with pain in IBD will provide a 
basis for developing a theory of IBD pain to underpin a psychosocial intervention, as has been applied 
in other conditions such as multiple sclerosis and paediatric chronic fatigue syndrome35,36.  
 
 
The specific aims of the study are to  
I) To systematically review psychological and social factors associated with pain in adults 
diagnosed with IBD. 
II) To assess the association of pain and clinical and sociodemographic factors within 
included studies of psychosocial investigations. 
 
Methods 
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The protocol for this review was prospectively registered on 23/03/2017(PROSPERO 42016052479). 
 
Eligibility criteria 
Studies were eligible if they reported on pain in an adult IBD population and measured at least one 
psychosocial factor. Studies including paediatric populations were not included, as it was contended 
that psychological processes compared to adult IBD-pain were likely to be different, for example the 
role of parent-child dyads. A focus on adult IBD-pain would therefore yield greater clarity in 
identifying key targets for a self-management intervention. Pain measures included any pain measure 
such as pain intensity, severity, diagnosis of chronic pain (> 3 months), pain-associated disability or 
interference. Inclusion and exclusion criteria for this review are presented in Table 1.   
 
Information sources, search and study selection 
Studies were identified through multiple online database and hand searching. Online searches were 
conducted in January and February 2017, and a final search was conducted on 24 May 2017. 
Databases included EMBASE (1974 to 2017 Week 2), Medline (1946 to 2017 Week 2) PsycInfo 
(1806 to 2017 Week 1), Web of Science, CINAHL and the Cochrane Library. Additional articles were 
identified manually by the first author through reference lists. Authors of abstracts and those known to 
be working in the field of IBD pain were contacted directly for any unpublished data. Search terms 
were tailored for each database and included terms for ‘inflammatory bowel disease’, ‘pain’ and 
‘psychosocial factors’ and combined using the set operators OR and AND (Table 2). MeSH and 
explode terms were utilised to maximise search results. Cross-sectional, prospective, longitudinal and 
experimental studies (reporting a baseline association of psychosocial factors and pain) were included. 
Only studies presented in English were selected (no scope for translation) however no restrictions 
were applied with regards to publication date due to the limited number of studies on psychosocial 
factors and pain in IBD. L.S. and L.M. independently carried out abstract and full-text screening using 
predetermined criteria. Any disagreements between reviewers were resolved through discussion 
utilising inclusion criteria. 
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Data collection  
Predefined data extraction criteria were used by two authors (L.S. and L.M.) to extract relevant data. 
Any discrepancies were again resolved by consensus or inclusion of a third author (C.N). Extracted 
information from each study included (1) study design (2) number of participants, (3) characteristics 
of patient sample (age, IBD diagnosis), (4) comparator group (if applicable) (5) recruitment source (6) 
type of (correlate) psychosocial measure, (7) type of (outcome) pain measure, (8) key findings (9) key 
quantitative data (10) additional clinical/demographic correlates with pain. Due to variety in pain and 
psychosocial measures used, meta-analyses were not possible and so a narrative review was 
conducted. 
 
Quality assessment 
 
Methodological quality of studies was assessed using the Critical Appraisal Skills Programme 
(CASP) guidelines, selected by the specific methodological design of included studies37. The same 
criteria have been applied in previous reviews on IBD populations38, 39. Studies were assessed by L.S. 
and L.M. and points were deducted for a lack of defined objectives and hypothesis; non-validated 
measurement tools; inappropriateness or limited data regarding methodological design and statistical 
analysis; selective reporting of results and limitations not addressed. Assessment of studies yielded a 
low, medium or high quality rating. Any disagreement between reviewers was resolved through 
consensus or inclusion of C.N. Studies were classified as High (n =10), Medium (n=4) and Low 
quality (n=1) (see Supplementary Table 1). As all papers were considered to contribute to the topic of 
interest, no studies were excluded on the basis of quality.  
 
Results 
 
Study characteristics 
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Combined database and manual searches identified 3336 references. After removing duplicates and 
undertaking title and abstract screening, full-texts of 65 studies were assessed by L.S and L.M. Fifteen 
studies reported in 16 papers were included (Figure 1). Studies excluded at the full-text screening 
stage, with reasons, are provided in Supplementary Table 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. PRISMA flow chart of included studies  
 
 
 
Results of individual studies 
 
 
The 15 studies included a total of 5539 IBD participants (including indeterminate colitis) and 993 
non-IBD participants. A wide variety of pain measures were used in studies, with a significant 
proportion of studies relying on single-item questions or sub-scores to assess pain. Moreover, there 
was wide variability in study design and methodology. Eight studies were cohort studies and seven 
were case-control studies. One study was reported in two papers40, 41. Three studies compared IBD 
with healthy controls40-43 and four studies involved other patient groups including back pain, IBS, 
Identification 
Screening 
Online records (PsycInfo, MEDLINE, 
Embase, Web of Science, CINAHL & 
Cochrane Library: 3336 
Manual search (author suggestions, 
reference lists & grey literature): 2 
Duplicates removed: 861 
Titles screened: 2475 Records excluded at title: 2261 
Abstracts screened: 214 Screening Records excluded at abstract: 149 
Eligibility Full texts assessed: 65 
Records excluded: 51 (with reasons: 
5 = unobtainable, 10 = no /ineligible pain 
measure, 5 = pain within composite score, 
26 = no associated psychosocial variable to 
pain, 2 = IBD patients <18 years, 1 = not 
IBD, 2 = ineligible study design. 
Included Included in review: 16 papers 
reporting 15 studies 
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arthritis and gastroesophageal reflux disease44-47. One study was longitudinal and 14 studies were 
cross-sectional design, of which one was baseline data from an intervention study48 and two were 
national cohort survey studies49, 50. A summary of included studies is provided in Table 3, with 
detailed results of each included study presented in Supplementary Table 1.  
25 psychosocial factors in relation to pain were identified, including emotional, cognitive, behavioural 
and personality factors. Ten and five studies conducted univariate and multivariate analyses, 
respectively (Table 4). A variety of pain presentations were investigated and different pain measures 
were used by the studies (Table 5). Two papers explored different pain presentations41, 51, including 
joint pain, chronic pain with a neuropathic component and migraine51. Prevalence of probable 
migraine and chronic pain were significantly higher in the IBD cohort compared to the general 
population51.  Prevalence of patients with IBD with chronic pain in studies ranged from 11.3-38%2, 51. 
Percentages of patients experiencing pain of at least moderate intensity at the time of study, or who 
had experienced pain within the last three months, ranged from 20.5.3-82.5% across studies.  
The 25 psychosocial factors identified were grouped into three broad categories; emotional, cognitive-
behavioural and personality factors, and are reviewed below. Addressing the second aim of the 
review, clinical and sociodemographic factors associated with pain identified within the reviewed 
studies are then reported. 
 
 
Emotional factors 
 
One study investigated the presence of a mood disorder (by physician diagnosis) in relation to pain52. 
From multivariate analyses, a co-existing mood disorder increased the odds of pain frequency and 
pain severity fivefold (OR 5.76, 95% CI 1.39, 23.89). 
 
Depression 
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10 of the 15 included studies explored depression in relation to pain, of which nine found that 
depression/depressive symptoms were significantly positively associated with higher pain intensity40-
44, 47, 51, 53, more locations of pain41 and reports that pain prevented and/or restricted activities50. All but 
one of these studies were cross-sectional in design. Assessing different pain presentations, one study 
found that higher Hospital Anxiety Depression (HAD) depression scores (4th quartile vs 1st quartile) 
were associated with a 3.44 increased risk of probable migraine, but were not found to correlate with 
joint pain, abdominal pain or chronic pain with a neuropathic component51. In the only longitudinal 
study identified in this review, pain at baseline correlated with depressive symptoms at baseline and 
six months47. Five of these studies used the Hospital Anxiety Depression Score (HADS) 
questionnaire. Two of these studies included a comparison group, namely IBS44 and patients with 
arthritis51.  
 
One study investigating depression stratified participants who had active and inactive disease, defined 
by colonoscopy and histological reports43. Mucosal inflammation did not show a significant 
association with pain rating. Depression scores remained the only significant predictor of greater pain 
ratings in multivariate analyses, after controlling for age, growth factors levels (neurturin NRTN) and 
ion channel density (transient receptor potential Ankyrin TRPA1) in the colonic mucosa. 
 
Anxiety 
 
Of the seven included studies that explored anxiety and pain, all found a significant positive 
association between these variables in cross sectional analysis2, 43, 44, 49, 51, 53. One study found that state 
but not trait anxiety significantly correlated with increased abdominal pain/tenderness, however this 
was deemed a low quality study44. Exploring the association between anxiety and different pain 
presentations, HAD anxiety scores significantly correlated with joint and overall pain severity and 
probable migraine in an IBD cohort, but not abdominal or chronic pain with a neuropathic component 
in one longitudinal study51. 
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The HADS questionnaire was used in one study to assess factors associated with mood disorders in 
IBD42, and found that abdominal pain was significantly associated with HAD anxiety in CD. Active 
disease (SCCAI/endoscopic active disease Baron’s score >1) and perceived stress independently 
predicted anxiety and depression scores in UC. Being an inpatient also predicted higher Fco HAD 
depression scores. 
 
Stress 
 
Four studies assessed levels of psychological stress, including perceived stress, in relation to pain46, 47, 
53, 54. All of these studies found significant and positive correlations between stress and pain 
intensity46, 47, 53, 54, pain-related interference53 and bodily pain54. In regression analyses, odds ratio for 
psychological stress (OR lowest 2.26, highest 12.17) and female gender (OR highest 3.19) increased 
with greater pain using three pain sub-scores54. Three out of four studies were cross-sectional in 
design, however one longitudinal study found only baseline pain scores correlated with baseline 
perceived stress47. 
 
Cognitive-behavioural factors 
 
Pain catastrophising  
 
Three studies investigated pain catastrophising, which refers to an exaggerated negative cognitive and 
affective interpretation of actual pain or an expected pain experience. It includes magnifying potential 
negative factors associated with pain, feelings of helplessness and an inability to disengage from pain-
related thoughts55. All three cross-sectional studies found that pain catastrophising was associated 
with greater pain reporting in IBD2, 40, 41. Participants who reported more than one location of pain 
also were found to catastrophise more about pain in one study that looked at pain phenotyping41. 
Phenotype 1, 2 and 3 represented abdominal pain, 1-2 locations (e.g. abdominal and lower back) and 
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3+ locations, respectively. In univariate analyses, all pain phenotype participants with IBD showed 
significantly higher scores for pain catastrophising compared to healthy controls. However, phenotype 
1 showed significantly lower scores for these two psychosocial measures compared to phenotype 2 
and 3, with no significant difference between the latter phenotypes41. One high quality study found 
that a tendency to catastrophise was a significant predictor of moderate to severe pain after controlling 
for active disease, measured by the Harvey Bradshaw Index (HBI) or SCCAI2. 
 
Coping 
 
Coping is an important construct in the context of chronic illness, and refers to an individual’s efforts 
to tolerate and resolve stressors that exceed his or her resources56. Three cross-sectional studies 
assessed the association between pain and coping, using a variety of measures. As measured by the 
Coping Strategies Questionnaire, one study found that having a catastrophising tendency predicted 
moderate to severe pain in multivariate analyses, as aforementioned2. However, in univariate analyses, 
ignoring sensations, praying and hoping, cognitive coping/suppression, helplessness and diverting 
attention/praying were all found to be significantly correlated to greater pain intensity and associated 
disability2. In this study, chronic pain was present in 38% of patients, of which chronic abdominal 
pain was the most frequently reported (91%) followed by joint pain (33%), back pain (33%) and 
chronic headache (33%)2. Moderate to severe pain was also associated with active disease according 
to the HBI or SCCAI. Excluding disease activity, there were no differences in other disease 
characteristics (medication, disease duration) between moderate-severe and mild pain reporters. 
 
Coping strategies were investigated in one study, which assessed pain in participants recruited online 
and in clinics, through pain sub-scales in the HBI, Short Inflammatory Bowel Disease Questionnaire 
and Short-Form 3654. These included emotion-focused coping (e.g. acceptance, humour, and 
emotional support use), problem-focused coping (e.g. active coping and planning) and unhelpful or 
‘dysfunctional’ coping (e.g. self-blame, denial and substance use). For the whole cohort, use of 
‘dsyfunctional’ strategies was the only coping strategy that significantly correlated with severe pain 
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across all three pain-sub scores (p <.001). In logistic regression analyses, dysfunctional coping 
showed significant increased odd ratios with mild pain (OR 1.06 in HBI and SF-36) and moderate 
pain (OR 1.07 in SIBDQ) (both p <.05). From the SIBDQ pain sub-score, use of problem-focused 
coping was associated with a 15% reduced risk of experiencing severe pain (p <.05). Emotion-focused 
coping showed no significant association with pain across pain sub-scores. Both illness-focused 
(guarding, resting behaviours) and wellness-focused coping (task persistence, relaxation) were 
positively associated with pain in one high quality study40 (Pearson r = 7.2 and 3.5 respectively). 
 
Knowledge and beliefs, perceived social support 
 
One study assessed participants’ knowledge of IBD and found no association with pain levels53. Most 
(70.6%) pain reporters said their doctor ‘did not understand their pain symptoms’. Significantly more 
patients reporting pain had active disease (defined by physician assessment), however no significant 
associations were found between age, alcohol consumption or disease duration and pain53. Lower 
beliefs in the effectiveness of pain medication was found to be associated with greater pain in 
multivariate analyses in another study2. In univariate analyses of this study, the extent to which 
participants believed that they were disabled by pain (disability score) significantly correlated with 
pain. A positive psychological factor, perceived social support, was significantly associated with less 
pain in one high quality cross-sectional study40, however this was not supported in a prospective study 
which found no association with social support and pain levels47.  
 
Pain fear avoidance  
 
Pain fear avoidance was investigated in IBD patients diagnosed with chronic pain, along with patients 
with back pain and heterogonous pain conditions (e.g. fibromyalgia and spinal pain syndromes)45.  
This construct explores individual’s beliefs of fearful or threatening situations, and is argued to 
exacerbate deconditioning and disability in the context of chronic pain57. In a cross-sectional design, 
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pain intensity correlated with pain fear avoidance across all three groups. No data were provided on 
disease activity.  
 
Personality factors 
 
Personality factors and bodily pain within a health-related quality of life (HRQoL) measure was 
investigated in one study48. Patients were recruited on the basis of a disease activity index for CD or 
UC of >4 (active disease) and perceived stress questionnaire score of > 60. In CD patients only, 
greater scores on a bodily pain sub-scale (demonstrating better pain-related quality of life) was 
associated with internal locus of control (p = .04). In regression analyses, although the overall model 
(including control variables) was not found to be significant in explaining bodily pain, the personality 
variable of internal locus of control remained significant. Pain levels were not associated with positive 
personality traits of gratitude, benefit finding or thriving in the only included longitudinal study47. 
 
Clinical and sociodemographic factors 
 
Addressing the second aim of this review, clinical or sociodemographic correlates of pain reported 
within included papers were extracted. Six out of 15 studies controlled for disease activity and/or 
clinical factors2, 43, 48, 51-53.Within these, four found an association between active disease and pain 
(three out of four measured by physician-reported disease activity index)2, 48, 51, 53, and one found an 
association between an inflammatory marker (C-reactive protein) and pain52. Abdominal pain showed 
no association with disease activity in two studies43, 51 and active disease only predicted pain in UC 
but not CD patients in another study48. Three studies found that psychosocial factors remained 
significant predictors of pain alongside active disease or markers of inflammation 2, 43, 51, 52.  One study 
found that depression remained the only significant predictor of pain ratings when controlling for 
clinical factors (r> .50)43. This study investigated the influence of ion channel density and 
neurotrophic factors on pain, which are upregulated as a result of inflammatory activity and can lead 
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to visceral hypersensitivity1. In univariate analyses, higher NRTN and lower TRPA1 levels in the 
mucosa correlated with higher pain ratings. Endoscopic findings and cytokine inflammatory markers 
(IL 1b, IL6, IL17) did not correlate with pain ratings43. Disease duration was associated with probable 
migraine51, but not found to be significantly associated with pain ratings in another study53. With 
regards to medication use, two studies found that no IBD-specific medications were associated with 
overall pain risk2, 51 and one found that only use of NSAIDS was significantly greater in the 
abdominal pain group52. As expected, opiate and paracetamol use increased in relation to pain severity 
groups in two2, 52 and three studies, respectively2, 52, 53.  
 
Seven studies assessed the relationship between gender and pain, and three found a significant 
association with pain and female gender51, 52, 54, including greater prevalence of migraine in females51.  
Younger age was associated with greater pain43, 52 and probable migraine51. In quiescent IBD, one 
study found that patients reporting frequent to constant levels of pain were significantly more likely to 
have a co-existing diagnosis of a mood disorder, a chronic pain syndrome, a diagnosis of IBS, were 
more likely to be female, be younger and have higher ESR (mm/hour) values52. 
 
 
 
Discussion 
 
This systematic review investigated psychosocial factors associated with pain in adults diagnosed 
with IBD. Emotional, cognitive-behavioural and personality factors were found to be associated with 
pain. The majority of studies were of high quality and had moderate to large sample sizes, lending 
weight to the conclusions of the review. Depression and anxiety were the most commonly explored 
psychosocial constructs in relation to IBD-pain. Findings indicate that higher levels of depression and 
anxiety are associated with greater pain severity/intensity. A recent systematic review identified 
prevalence rates of 15% and 20% for depression and anxiety in over 150,000 IBD patients, 
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respectively58. Prospective studies with IBD patients have demonstrated that depression and anxiety 
are associated with symptom exacerbation and onset of active disease59-62. The current review 
suggests that pain may be one of the symptoms associated with these psychological factors. Higher 
levels of perceived stress were also a significant correlate of IBD-pain44, 46, 53, 54, which supports 
previous evidence demonstrating the effects of stress on symptom exacerbation via the gut-brain 
axis16, 63. Negative emotional arousal may exacerbate pain in IBD directly through amplification of 
descending pain signals in higher order processing or by exacerbating inflammation via the 
production of cortisol1. Alternatively, greater negative affect may contribute to unhelpful behaviours 
such as withdrawal or poor medication adherence, which can affect pain levels. The negative 
emotional factors identified in this review have been recognised in the IBS literature and served as 
targets for therapeutic change in non-pharmacological interventions for patients with IBS64, 65, 
supporting the view that IBS and IBD may share some similar pain mechanisms. 
 
Exacerbation of pain symptoms from emotional arousal may also link to cognitive-behavioural 
factors. Greater catastrophising was associated with pain across several studies, which has been 
recognised as a contributing factor to chronic pain in conditions such as such as multiple sclerosis and 
fibromyalgia66, 67. Moreover, research in IBS has shown a mediating role of pain catastrophising 
between depression and abdominal pain68. A number of studies examined coping strategies in relation 
to pain levels40, 54. Greater use of behaviours such as self-distraction, behavioural disengagement, 
denial, venting and self-blame (labelled ‘dysfunctional’ coping) and less use of active coping and 
planning (labelled ‘problem-focused’ coping) were related to increased pain severity. Emotionally-
focused coping strategies (acceptance, humour, positive framing) showed no relation to pain levels. In 
another reviewed study, both ‘wellness’ and ‘illness’-focused coping were investigated. Wellness-
focused coping addresses behaviours that aim to facilitate pain control, such as exercise/stretching, 
task persistence and relaxation, whereas illness-focused coping includes withdrawal behaviours and 
giving up on an attempt to control the pain, such as guarding, resting and asking for assistance. Both 
types of coping were positively associated with increased pain intensity. These conflicting results 
suggest that the relation of over-arching coping styles to IBD-pain is unclear. One could argue that the 
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use of emotionally focused techniques, such as acceptance and humour, may be adaptive or 
‘functional’ for an individual in a given context. In this regard, identifying specific unhelpful thoughts 
and behaviours in relation to pain, such as denial, self-blame and fear avoidance45, may be more 
effective targets than overarching coping styles for intervention development.  
 
A number of positive psychological factors were explored in studies identified in the current review. 
Perceived social support and problem-focused coping were negatively associated with pain40, 54. An 
internal locus of control48, namely the perception that one’s behaviour can control events and 
outcomes was associated with better pain-related quality of life. Research on chronic back pain has 
shown that individuals with an external locus of control are more likely to rely on maladaptive coping 
strategies such as low levels of activity and a lack of belief in recovery69, 70. This has been supported 
in research on IBD cohorts with back and joint pain71. Perceived controllability of stressful life events 
has been investigated in individuals with functional gastrointestinal disorders, and has demonstrated 
that developing skills of coping flexibility, in particular learning to identify and respond adaptively to 
controllable versus uncontrollable stressors, may be a useful tool for patients with more complex 
symptoms72. One study found that acceptance of pain significantly positively correlated with 
resilience and negatively correlated with low mood in IBD patients with chronic pain49. This may 
suggest that targeting pain-related thoughts such as pain acceptance may indirectly reduce pain 
symptoms by improving mood. Positive psychological factors such as pain acceptance and resilience 
may be important avenues to explore with regards to pain adaptation, and as possible therapeutic 
mechanisms for future psychological interventions for IBD-related pain. 
 
The review did not find a clear relationship between active disease/inflammation and pain. Previous 
studies have demonstrated an association between mucosal signalling molecules, such as an increase 
in pain nerve fibres TRPA1/TRPN1, and greater pain73, 74. However this was not supported by one 
reviewed study43. This demonstrates the complexity of identifying clinical factors related to pain in 
IBD, and requires further clarification. The majority of studies that controlled for disease activity 
found that psychosocial factors remained significant predictors of pain levels regardless of disease 
20 
 
activity. This supports the role of a biopsychosocial approach to IBD-pain, and highlights the need to 
take an integrative approach when assessing patients’ symptoms and quality of life, in periods of both 
active and inactive disease.  
 
The review identified that females and younger adults may be at particular risk of experiencing or 
reporting pain43, 51, 52, 54. However, no gender differences were noted for different types of pain 
presentations which has been highlighted in a study by Schirbel and colleagues, who found greater 
rates of arthralgia in females3. This study by Schirbel et al. was not eligible for the review as no 
explicit psychosocial measure was included separate from HRQoL. However, in 400 IBD patients, 
87.9% reported pain, 48.2% reported persistent pain and 38.3% of patients reported that pain was 
intensified by mental stress3.  
 
The current review confirms the role of emotional and cognitive factors in relation to pain in IBD, as 
proposed by Bielefeldt et al1 in their model of IBD-pain. However, their model has a particular focus 
on anxiety and mood disorders, rather than addressing pain-specific emotions, cognitions and 
behaviours. This review has identified pain-specific psychosocial processes that may be important 
mechanisms of chronic pain in IBD, such as pain catastrophising and pain fear avoidance. In addition, 
results from the review suggest that positive psychological factors such as active coping, internal 
locus of control, resilience and pain acceptance may be buffering or ‘protective’ factors against more 
severe or chronic IBD-pain40, 53, 54. Psychological therapies may therefore be beneficial to patients 
with chronic pain in IBD and particularly those with psychological distress and unhelpful thought 
processes. CBT has a large evidence-base for treatment in IBS and other functional gastrointestinal 
disorders75-78, as well as positive outcomes for quality of life and coping skills in IBD populations30, 65. 
Further research is required to confirm the role of negative psychological factors, including 
depression and anxiety, and pain-specific cognitive-behavioural factors in relation to chronic pain in 
IBD. Additionally, the potential buffering effects of positive psychological factors on pain identified 
in the review warrants further investigation.  
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Limitations  
 
Despite identification of key factors associated with pain in IBD, limitations must be acknowledged. 
Although a number of studies controlled for disease activity, only one stratified results based on 
patients with active and inactive disease52. Patients with active disease were included in the review as 
studies examining patients only in remission and fulfilling eligibility criteria were sparse in 
preliminary searches. Therefore, investigation of pain in patients in remission specifically was limited 
in this review. A substantial number of reviewed studies lacked the inclusion of a specific validated 
pain measure; eight out of 15 studies used either the pain sub-measure from HRQoL, disease activity 
index questionnaires or single items in questionnaire surveys49, 50. The use of validated pain scales 
with broader profile of pain is recommended for pain assessment, including pain location, 
intensity/severity, pain interference and pain-related beliefs79, 80. These constructs are also 
recommended as key outcome measures in pain clinical trials81. 
 
Ongoing pain in IBD remission has been discussed in relation to IBS and conceptualised as IBS-IBD 
or more recently ‘irritable inflammatory bowel syndrome’82. In support, one study found that patients 
with quiescent UC but reporting frequent to constant levels of pain were more likely to have a 
diagnosis of IBS (and chronic pain syndromes), alongside a mood disorder52. As IBS and IBS-IBD 
were not the main focus of this review, these were not included in the search terms. In addition, it was 
felt by the authors that exploration of IBD-pain in isolation rather than the addition of IBS-IBD would 
have yielded a purer review on IBD pain, rather than with accompanying gastrointestinal or functional 
symptoms. At the screening stage, studies were not excluded if they involved IBS-IBD patients, but 
were excluded if pain was measured only within an IBD or IBS composite score. Therefore, although 
studies on IBS-IBD were considered for this review pending eligibility criteria, a large number of 
papers on IBS-IBD or functional symptoms in IBD may have provided a more comprehensive profile 
of psychosocial factors associated with pain in IBD. In addition, it may have yielded more studies 
examining IBD patients exclusively in remission. 
22 
 
 
All but one of the included studies were observational studies, therefore direction of causality cannot 
be determined. Future research would benefit from longitudinal studies to assess whether 
psychosocial factors can predict variation in pain ratings over time. Lastly, only one of the 15 
included studies carried out a power calculation51. Further exploration of psychosocial factors and 
pain in would be strengthened by prospective studies and use of statistical power analyses. Further 
recommendations for observational and intervention studies are summarised in Table 6. 
 
Clinical implications of key findings 
 
The review suggests a number of implications for clinical practice. A recent systematic review on 
chronic abdominal pain management in IBD presented promising findings for psychosocial 
interventions, including stress management techniques and coping skills training26. Results from this 
review support the application of a psychosocial intervention, alongside IBD medication, for pain 
management. In particular, the consistent association identified between depression and anxiety and 
pain in the present review suggests that treatment of mood-related issues may improve pain levels and 
pain-related quality of life. Additionally, targeting pain-specific thoughts and behaviours such as pain 
catastrophising and fear avoidance may in turn show beneficial effects on mood as well as pain. The 
review also indicates that positive psychology may be an important avenue to explore in relation to 
treatment for pain. Active coping and perceptions of control and social support were associated with 
lower pain levels in this review. In addition, pain acceptance and resilience/psychological well-being 
may be useful targets for an intervention in buffering the impact of pain on patients with IBD. Further 
research is required to explore the role of negative ‘risk’ factors and positive ‘protective’ 
psychological factors in relation to IBD-pain, to aid the development of effective and disease-specific 
psychological treatment. 
 
Conclusions and recommendations 
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This is the first review to systematically explore the role of psychosocial factors related to IBD-pain. 
The emotional, cognitive, behavioural and personality factors identified here are consistent with other 
systematic reviews on disease-specific pain and the chronic pain literature. In addition, the review has 
presented similarities between IBD and IBS pain, and supports the view that application of IBS-pain 
management approaches may be useful in the context of IBD, such as cognitive behavioural therapy. 
It is recommended that further research aims to confirm the importance of emotional factors and 
explore both negative and positive cognitive content and behavioural responses to pain. Further 
research in this area, with use of power calculation of sample sizes and validated pain measures, 
should help to build a more comprehensive understanding of IBD-related pain.  
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Table 1. Inclusion and exclusion criteria for studies 
 Inclusion criteria Exclusion criteria 
Population Adults ≥18 years with IBD 
Active and inactive disease 
Patients < 18 years 
Adults without a diagnosis of IBD 
Exposure/correlate Psychological factors 
Personality factors 
Social factors 
Demographic/clinical factors only 
Control/comparison No comparator 
IBD without pain 
Chronic pain associated with another 
condition 
 
Outcomes Pain intensity/severity 
Pain-related interference 
Pain-related quality of life 
Chronic pain 
Bodily pain 
Abdominal pain 
Joint/musculoskeletal pain 
Pain assessed only within IBS or 
IBD composite score and not 
reported separately 
Post-operative pain 
Experimentally induced pain/pain 
threshold study 
Study design Prospective, longitudinal and 
experimental studies (if reporting 
baseline associations) 
Non-empirical, qualitative or 
review papers 
Studies not published in English 
 
 
 
 
Table 2. Search terms entered into databases  
IBD terms AND Pain terms     AND Psychosocial factors terms 
25 
 
Inflammatory 
bowel disease 
IBD (OR) 
Ulcerative 
Colitis (OR) 
UC (OR) 
Crohn’s 
Disease (OR) 
CD (OR) 
 
 Pain (OR) 
Chronic pain (OR) 
Chronic abdominal 
pain (OR) 
Abdominal pain 
(OR) 
Persistent pain 
(OR) 
Pain interference 
(OR) 
Pain-related* (OR) 
 
 Psycholog* (OR) 
Psychosocial* (OR) 
Social* (OR) 
Illness beliefs (OR) 
Catastrophi?ing (OR) 
Anxi* (OR) 
Depress* (OR) 
Affect* (OR) 
Mood* (OR) 
Cop* (OR) 
Avoid* (OR) 
Fear* (OR) 
Cogniti* (OR) 
Perception (OR) 
Accept* (OR) 
Biopsychosocial (OR) 
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Reference Study 
design 
Psychosocial factor investigated Pain measure 
Pain location 
Key findings Quality 
Boye 200848 Cross-
sectional 
BussPerry Aggression 
Eysenck Personality Questionnaire 
Multidimensional Health Locus of 
Control Scale 
Toronto Alexithymia Scale 
Short Form-36  
 
Bodily pain 
High internal locus of control associated with higher pain-related quality 
of life in CD. 
High 
Boyle 201553 Cross-
sectional 
Stress - Anxiety -Depression  
(21 score) 
Crohn’s and Colitis Knowledge  
Brief Pain Inventory 
 
Abdominal pain 
Mean scores in the SAD-21 for anxiety, depression and stress were 
significantly greater in pain reporters. 
Medium 
Coates 201352 Cross-
sectional 
Mood disorder  SIBDQ Pain Score  
Modified 
ulcerative colitis disease activity index 
survey  
 
Abdominal pain 
Patients with higher pain more frequently carried a concurrent diagnosis 
of a mood disorder. (OR 5.76, 95% CI 1.39–23.89) 
High 
Deberry 
201443 
Cross-
sectional 
Hospital Anxiety and Depression 
Scale 
VAS 
McGill Short Form Questionnaire 
 
Abdominal pain 
Patients with UC with pain had significantly higher HADS when 
compared with controls and patients with UC without pain - UC with 
pain. Higher depression scores independently predicted pain in UC 
patients (r > 0.5)  
High 
Edman 
201746 
Cross-
sectional 
Perceived Stress Scale 
 
Self-report numerical rating scale of 
pain 
 
Unspecified location 
Perceived stress significantly positively correlated with average pain (r 
= 0.32, p <.0001) and worst pain (r = 0.35, p <.01) in the IBD group. 
High 
Esteve 201345 Cross-
sectional 
Acceptance and Action 
Questionnaire 
SF-36 bodily pain 
Pain intensity scale 
 
Chronic pain 
Bodily pain 
Across all three groups, pain intensity (and experiential avoidance) 
correlated with pain fear avoidance (beta = .19, p <.05) 
High 
Fuller-
Thomspon & 
Sulman 
200650 
Cross-
sectional  
Depression (Kessler and Mroczek 
scale) 
Pain items in survey questionnaire 
 
Unspecified location 
Respondents whose activities were limited by pain (depressed = 35.1% 
vs non-depressed = 58.4%, p <.001) and who were in severe pain were 
much more likely to be depressed.  Those who reported that activities 
were prevented by pain were significantly more depressed. 
Medium 
Fuller-
Thompson 
201549 
Cross-
sectional 
Generalised anxiety disorder Pain items in survey questionnaire 
 
Unspecified location 
Anxiety was predicted by chronic pain (OR 2.43) Medium 
Goodhand 
201242 
Cross-
sectional 
Hospital Anxiety and Depression 
Scale 
Harvey Bradshaw Index  
 
Abdominal pain 
Chi-squared analyses showed a significant association between 
abdominal pain and HADS-A scores in CD patients. 
High 
Table 3.  Summary of results from included studies 
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Moisset 
201751 
Cross-
sectional 
Hospital Anxiety and Depression 
Scale 
International Classification of Headache 
Disorders’ diagnostic criteria  
Headache Impact Test  
DN4-interview questionnaire British 
Pain Inventory 
 
Abdominal pain 
Arthralgia 
Migraine 
Chronic pain with neuropathic pain 
Depression significantly associated with probable migraine. HAD 
anxiety was significantly associated with arthralgia/joint pain. HAD 
anxiety was significantly associated with overall pain. 
 
High 
Morrison 
20132 
Cross-
sectional 
Survey of Pain Attitudes 
Coping Strategies Questionnaire 
Hospital Anxiety and Depression 
Scale 
von Korff Pain Intensity and Disability 
questionnaire 
 
Chronic pain 
Abdominal, joint, headache, back pain 
(Results for overall pain score) 
Independent and significant associations with moderate-severe pain 
were catastrophising tendency (OR 34.69), depression (OR 1.8), 
medication beliefs (OR .05) and active disease (OR 48.54). 
High 
Odes 201754 Cross-
sectional 
Brief Symptom Inventory, Brief 
COPE Inventory, Family 
Assessment Device, Satisfaction 
with Life Scale, Work Productivity 
and Activity Impairment 
Harvey Bradshaw Index 
Short Inflammatory Bowel Disease 
Questionnaire (SIBDQ) 
SF-36 bodily pain 
 
Abdominal pain 
Bodily pain 
Higher pain scores significantly correlated with psychological stress, 
dysfunctional coping strategies, poor family relationships, work 
absteenism, presenteeism, productivity loss and activity impairments 
and all WPAI sub-measures. 
High 
Schwarz 
199344 
Cross-
sectional 
Beck Depression Inventory 
State-Trait Anxiety  
Psychosomatic Symptom Checklist 
Daily symptom diary (0-4 scale) 
 
Abdominal pain 
Pain/tenderness significantly correlated with all psychological measures 
excluding STAI-trait. 
Low 
Sirois & 
Wood 201747 
Longitudi
nal  
Gratitude (Q-6) 
Depression Scale  
Perceived Stress Scale 
Duke-UNC Functional Social 
Support questionnaire 
Bowel Symptoms sub-scale 
(Inflammatory Bowel Disease 
Questionnaire) 
 
Abdominal pain 
T1 pain significantly positively correlated with T2 depressive 
symptoms, T2 pain, perceived stress and helplessness, and negatively 
correlated with T1 self-rated health measured by SF-36 (all p <.01). T2 
pain significantly correlated with T1 pain and perceived stress (all p 
<.01) 
Medium 
Tripp (paper 
1) 201541 
Cross-
sectional 
Pain Catastrophising Scale  
Depression (PHQ-9) 
Short Inflammatory Bowel Disease 
Questionnaire 
Short Form McGill Pain Questionnaire 
Pain body Diagram 
 
Abdominal pain 
1, 2, >3 locations 
All IBD pain phenotype groups reported more pain catastrophising and 
depressive symptoms than controls. Patients with IBD abdominal pain 
reported significantly less pain catastrophising (p<.01) and depressive 
symptoms (p<.001) than IBD patients with 1-2/3+ pain locations. 
High 
Tripp (paper 
2) 201540 
Cross-
sectional 
Chronic Pain Coping Inventory  
Pain Catastrophizing Scale 
Depression (PHQ-9) 
Multidimensional Scale of 
Perceived Social Support  
Bowel Disease Questionnaire 
Short Form McGill Pain Questionnaire 
Pain body Diagram 
 
Unspecified location 
 
Pain associated with illness-focused coping (r =.7), pain catastrophising 
(r = .52), wellness-focused coping (r = .35), depressive symptoms (r 
=.68) and perceived social support -.26). 
High 
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Table 4. Factors associated with pain identified in included studies 
 
If provided, p ≤.05 *, p =≤.01 **, p ≤.001 ***. NB inflammatory markers include histology, endoscopy, calprotectin, C-reactive protein. TPRV1/TRPVA1 = 
transient receptor potential cation channel subfamily V1/ ankyrin 1 . +/- indicate positive or negative associations.                                                                           
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Psychosocial                
Depression  +***  +*   +***   + +*  +*** +** +** 
Anxiety  +***  NS    + +* +   +*   
Mood disorder   +*             
Stress  +***   +***       +***  +**  
Somatisation             +***   
Pain catastrophising           +**    +*** 
Helplessness              +** + 
Medication beliefs           -**     
IBD knowledge  NS              
Dysfunctional coping            +*    
Problem focused coping            -*    
Emotion focused coping            +    
Illness focused coping               +** 
Wellness focused coping               +** 
Pain fear avoidance      +          
Internal locus of control +**               
Neuroticism NS               
Hostility/aggression NS               
Alexithymia NS               
Conventionality NS               
Perceived Social Support              NS -** 
Benefit Finding              NS  
Illness Acceptance              NS  
Gratitude              NS  
Thriving              NS  
Clinical/demographic                
Disease activity index +*** +* +**       +** +*     
Disease duration  NS        +      
Female gender   +*       +  +***    
Age  NS NS -*      -      
Inflammatory markers 
(ESR/CRP/calpro/endosc) 
  +* NS            
TRPV1/TRPVA1    NS            
Opioid use   +**             
Antidepressant use   +*             
Units of alcohol p/week  NS              
Chronic pain syndrome   +*             
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Table 5. List of pain presentations and pain measures in reviewed studies 
 
 
 
 
 
 
 
 
Type of pain Pain measure No. of 
studies/reference 
Abdominal pain Short inflammatory bowel disease questionnaire pain item 
Modified UC disease activity index 
Harvey Bradshaw Index pain item 
Daily symptom diary 
Bowel Symptoms sub-scale (IBDQ) 
Visual analogue score 
Short Form McGill Questionnaire 
2 52, 54 
152 
2 42, 54 
144 
147 
143 
143 
Unspecified location of pain Brief Pain Inventory 
Self-report numerical rating scale 
Pain intensity scale 
Single pain survey item 
Von Korff Pain intensity and Disability  
Short Form McGill Questionnaire 
153 
146 
145 
249, 50 
12  
2 (papers) 40, 41 
Bodily pain/ pain-related quality of life SF-36 3  
Joint pain/arthralgia   Brief Pain Inventory 151 
Migraine  International Classification of Headache Disorders 151 
Chronic pain Participant screening item 22, 51 
Chronic pain (neuropathic component) DN4-interview questionnaire 1 
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Table 6. Recommendations for future observational and intervention studies  
Study type Recommendations 
Observational studies  Validated pain measure 
 Neuropathic pain measure 
 Long-term follow up  
 Objective marker of disease activity 
 Exploration of positive and negative psychosocial factors  
 Sample size power calculation  
Intervention studies  Intervention based on theoretical principles 
 Validated pain measure  
 Clear stratification of active and remission patients (or 
recruitment of remission patients only) 
 Control group 
 Objective marker of disease activity 
 Long term follow-up  
 Sample size power calculation  
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